#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dermatitis Cytokine release syndrome Skin angiosarcoma Biliary cancer metastatic Adenocarcinoma pancreas Acute myeloid leukaemia refractory Pleural mesothelioma Pustular psoriasis Von Willebrand's disease Breast cancer metastatic Pulmonary sarcoidosis Synovial sarcoma metastatic Acromegaly Malignant glioma Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Diagnostics Nephrotic syndrome – Life with Disease Methylmalonic acidaemia – Treatment Mucopolysaccharidosis I – Basic Information Gaucher’s disease type I Mastocytosis Factor VIII deficiency – Life with Disease Nodal marginal zone B-cell lymphoma – Treatment Pituitary-dependent Cushing’s syndrome – Diagnostics Malignant fibrous histiocytoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tavapadon Prednisolone Sodium Phosphate Methylprednisolone Acetate PICLIDENOSON Acemetacin Fenebrutinib Tilsotolimod Sodium Aavanc80-3'Hotof Mps-102 Vincristine Sulfate Iomeprol Siponimod Caffeine Citrate Altizide Perflutren Ep262 Semaglutide 99MTC-EUK-(SO3)CY5-MAS3 Patisiran Febuxostat Hemihydrate More therapies…

    Learn about Your Condition

    Paraganglion neoplasm Neutropenia Vaginal haemorrhage Fatty acid oxidation disorder Thromboangiitis obliterans Lymphoedema Carotid artery stenosis Hyperglycaemia Electronic cigarette user Intestinal ischaemia Hepatobiliary cancer Hypoaesthesia Nephrolithiasis Hyperoxaluria Testicular leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary arterial hypertension

  • Study on Inhaled Seralutinib (GB002) for Patients with Pulmonary Arterial Hypertension (PAH)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Czechia Germany Spain

  • Study on the Safety and Effectiveness of Cibotercept (KER-012) with Other Drugs for Adults with Pulmonary Arterial Hypertension

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Cibotercept
    France Germany Poland Portugal Spain

  • Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

    Not recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Imatinib
    Austria Belgium Czechia France Germany Greece +8

  • Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Imatinib
    Austria Belgium Czechia France Germany Greece +8

  • Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Austria Belgium Czechia Denmark France Germany +10

  • Study on Treprostinil Palmitil Inhalation Powder for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Treprostinil Palmitil
    Austria Belgium Denmark Germany Italy Spain
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!